ATE205847T1 - 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel - Google Patents

5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel

Info

Publication number
ATE205847T1
ATE205847T1 AT97900236T AT97900236T ATE205847T1 AT E205847 T1 ATE205847 T1 AT E205847T1 AT 97900236 T AT97900236 T AT 97900236T AT 97900236 T AT97900236 T AT 97900236T AT E205847 T1 ATE205847 T1 AT E205847T1
Authority
AT
Austria
Prior art keywords
indeno
nmda
imidazo
pyrazine
production
Prior art date
Application number
AT97900236T
Other languages
English (en)
Inventor
Jean-Claude Aloup
Jean Bouquerel
Dominique Damour
Jean-Claude Hardy
Patrick Jimonet
Franco Manfre
Serge Mignani
Patrick Nemecek
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE205847T1 publication Critical patent/ATE205847T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT97900236T 1996-01-10 1997-01-06 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel ATE205847T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9600192A FR2743366B1 (fr) 1996-01-10 1996-01-10 Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
PCT/FR1997/000019 WO1997025328A1 (fr) 1996-01-10 1997-01-06 DERIVES DE 5H,10H-IMIDAZO(1,2-a)INDENO(1,2-e)PYRAZINE-4-ONE, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CONTENANT______________________________________________________________

Publications (1)

Publication Number Publication Date
ATE205847T1 true ATE205847T1 (de) 2001-10-15

Family

ID=9487995

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900236T ATE205847T1 (de) 1996-01-10 1997-01-06 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one derivate antagonisten der rezeptoren ampa und nmda, ihre herstellung und zwischenprodukte und sie enthaltende arzneimittel

Country Status (20)

Country Link
US (2) US5990108A (de)
EP (1) EP0880522B1 (de)
JP (1) JP2000505073A (de)
KR (1) KR19990077135A (de)
AR (1) AR005424A1 (de)
AT (1) ATE205847T1 (de)
AU (1) AU1383097A (de)
BG (1) BG102618A (de)
CA (1) CA2239254A1 (de)
CZ (1) CZ216698A3 (de)
DE (1) DE69706830T2 (de)
DK (1) DK0880522T3 (de)
ES (1) ES2164323T3 (de)
FR (1) FR2743366B1 (de)
MX (1) MX9805167A (de)
PL (1) PL327942A1 (de)
PT (1) PT880522E (de)
SK (1) SK93498A3 (de)
WO (1) WO1997025328A1 (de)
ZA (1) ZA9786B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
EP1071648A2 (de) * 1998-03-13 2001-01-31 Merck Frosst Canada & Co. CARBONSÄUREN UND ACYLSULFONAMIDE, SOLCHE VERBINDUNGEN ENTHALTENDE Gemenge UND BEHANDLUNGSVERFAHREN
DE60226756D1 (de) * 2001-10-04 2008-07-03 Merck & Co Inc Heteroarylsubstituierte tetrazolmodulatoren des metabotropischen glutamatrezeptors-5
JPWO2003070722A1 (ja) * 2002-02-21 2005-06-09 アルフレッサファーマ株式会社 イミダゾール誘導体の改良製法およびその新規中間体
GB0415320D0 (en) * 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CN110996948A (zh) 2017-06-12 2020-04-10 格莱泰施有限责任公司 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2732681B1 (fr) * 1995-04-05 1997-07-04 Rhone Poulenc Rorer Sa Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant

Also Published As

Publication number Publication date
CZ216698A3 (cs) 1998-10-14
EP0880522B1 (de) 2001-09-19
SK93498A3 (en) 1998-12-02
PL327942A1 (en) 1999-01-04
FR2743366B1 (fr) 1998-02-06
WO1997025328A1 (fr) 1997-07-17
AR005424A1 (es) 1999-06-23
FR2743366A1 (fr) 1997-07-11
DK0880522T3 (da) 2002-01-21
PT880522E (pt) 2002-05-31
US6100264A (en) 2000-08-08
MX9805167A (es) 1998-10-31
BG102618A (en) 1999-09-30
AU1383097A (en) 1997-08-01
CA2239254A1 (fr) 1997-07-17
JP2000505073A (ja) 2000-04-25
DE69706830T2 (de) 2002-04-25
DE69706830D1 (de) 2001-10-25
ES2164323T3 (es) 2002-02-16
US5990108A (en) 1999-11-23
KR19990077135A (ko) 1999-10-25
EP0880522A1 (de) 1998-12-02
ZA9786B (en) 1997-07-17

Similar Documents

Publication Publication Date Title
EP0442878A4 (en) Derivatives of tryptophan as cck antagonists
DE69622183D1 (de) Chinolinderivate und chinazolinderivate welche die autophosphorylierung des von blutplättchen abstammenden wachstumsfaktorrezeptors inhibiren und sie enthaltende pharmazeutische zusammensetzungen
PL326083A1 (en) Novel pyrimidin derivatives as antagonists of 5ht 2c receptor
NZ223772A (en) Substituted benzodiazepine derivatives and pharmaceutical compositions
NZ301265A (en) Indole derivatives as 5ht receptor antagonists, preparation and pharmaceutical compositions thereof
HUP0004926A3 (en) 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring, pharmaceutical compositions containing them and their use
AR002039A1 (es) Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación
DE69715009D1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
EP0707581A1 (de) Indolin derivate als 5 ht2c antagonisten
EG20279A (en) New derivatives of 3 arylpyrazoles used as fungicides
HUP0003748A3 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives, process for their preparation their use and pharmaceutical compositions containing the same
AU3461293A (en) Benzodiazepine derivatives, as CCK and gastrin antagonists
HUP9702509A3 (en) Derivatives of fused heterocycles substituted on the aminogroup, process for producing them, their use and pharmaceutical compositions thereof
AU3573793A (en) 3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidine-4-ones pharmaceutical compositions containing the same and the preparation thereof
DE69706830D1 (de) 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATE ANTAGONISTEN DER REZEPTOREN AMPA UND NMDA, IHRE HERSTELLUNG UND ZWISCHENPRODUKTE UND SIE ENTHALTENDE ARZNEIMITTEL
FI951555L (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
AU6143694A (en) Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists
ATA269688A (de) Neue alkoxyderivate der ginkgolide, ihre herstellung und sie enthaltende therapeutische zusammensetzungen
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
HUP9601712A3 (en) Substituted benzothiazine derivatives, intermediates of them, process for their preparation and pharmaceutical compositions containing the same
NO953050D0 (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
ATE207923T1 (de) 5h, 10h-imidazo (1,2-a) indeno (1,2-e) pyrazin -4-one derivate ihre herstellung und diese enthaltende arzneimittel
IL95409A0 (en) Substituted n-heterocyclic five-membered ring derivatives,their preparation and pharmaceutical compositions containing them
IL95408A0 (en) Substituted heterocyclic fivemembered ring derivatives,their preparation and pharmaceutical compositions containing them
FI965186A0 (fi) 1,2,5,6-Tetrahydropyridiinijohdannaisten käyttö rauhoittavien lääkkeide valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee